FitLife Revenue Soars 73% on Irwin Deal, But Profits Feel the Squeeze

OMAHA, NE – April 01, 2026 – FitLife Brands, Inc. (NASDAQ: FTLF) today announced blockbuster fourth-quarter revenue growth of 73%, a figure largely fueled by its landmark acquisition of Irwin Naturals. However, the impressive top-line performance masks a more complex financial picture, with the nutritional supplement provider reporting a concurrent drop in net income and squeezed profit margins, signaling significant integration challenges and broader market headwinds.

The Omaha-based company's total revenue for the fourth quarter of 2025 reached $25.9 million, a substantial jump from $15.0 million in the same period of 2024. For the full year, revenue climbed 26% to $81.5 million. Yet, beneath these gains, net income for the quarter fell to $1.6 million from $2.1 million a year prior, and full-year net income declined to $6.3 million from $9.0 million in 2024. This divergence highlights the high cost and strategic trade-offs of the company's aggressive growth-through-acquisition strategy.

The Irwin Acquisition Paradox

The primary driver of FitLife's revenue surge and profitability dip is the August 2025 acquisition of Irwin Naturals. The deal, a $42.5 million asset purchase of the then-bankrupt supplement maker, immediately reshaped FitLife's financial landscape. In the fourth quarter alone, Irwin contributed $11.2 million in wholesale revenue, more than tripling FitLife's total wholesale figures year-over-year.

This inorganic growth, however, came at a cost. The company's gross margin fell sharply to 34.5% in the fourth quarter, down from 41.4% a year earlier. Officials attributed this primarily to integrating Irwin, which has historically operated with lower margins than FitLife's legacy business. After excluding acquisition-related accounting effects like a $0.7 million inventory step-up amortization, the adjusted gross margin stood at 37.0%, still well below the prior year's level. The decline in net income was similarly impacted by transaction expenses associated with the complex deal.

The acquisition was funded through significant new debt, including a $40.6 million term loan, which has shifted FitLife's balance sheet from a low-debt position to a more leveraged one, with total net debt standing at approximately $43.1 million at year's end.

A Tale of Two Portfolios

The 2025 results paint a picture of a company managing two distinct narratives: the promising, high-growth potential of the newly integrated Irwin brand and the stagnating performance of some of its core legacy brands.

A significant bright spot is the rapid success of Irwin products on Amazon. FitLife, leveraging its e-commerce expertise, took Irwin's Amazon presence from zero at the start of the quarter to approximately $500,000 in sales in the month of December alone. This momentum has continued into 2026, with CEO Dayton Judd noting that monthly revenue on the platform has now scaled to approximately $0.8 million.

"In a few short months, this has become a business with roughly $9-10 million of annual revenue on a run rate basis, with margins higher than our traditional wholesale business," Judd stated in the release.

This online success contrasts sharply with the performance of FitLife's legacy brand portfolio, which saw revenue decline by 12% in the fourth quarter. The primary drag came from the Mimi's Rock Corporation (MRC) family of brands, acquired in 2021, which saw a 15% revenue drop over the course of 2025. Market analysis suggests the decline is concentrated in its flagship Dr. Tobias brand, which has suffered from reduced traffic on Amazon. As a historically Amazon-exclusive brand, Dr. Tobias appears to have been negatively affected by shifts in the platform's algorithm that now favor brands driving external traffic.

Navigating Economic Headwinds and Debt

Compounding the internal brand challenges are macroeconomic pressures. Judd acknowledged "emerging weakness" across most brands and channels that has persisted into the first quarter of 2026. He pointed to "broad-based consumer confidence concerns" and declining discretionary spending as consumers grapple with economic and political volatility.

While the nutritional supplement market has shown resilience, with many consumers viewing wellness as an essential expense, inflationary pressures have led to more budget-conscious behavior. This includes "trading down" to lower-cost options or reducing the number of supplements purchased, a trend that could be impacting FitLife's established, higher-priced legacy products.

Against this challenging backdrop, the company is executing a dual strategy: aggressively paying down its new debt load while simultaneously investing in a turnaround. FitLife made a scheduled $1.5 million payment on its term loan and reduced its revolver balance in the fourth quarter, followed by another $1.4 million revolver paydown and a $1.5 million term loan payment in early 2026. "We intend to continue allocating our available free cash flow to debt reduction," Judd affirmed.

A Five-Point Plan for the Future

To address the multifaceted challenges, management has outlined a five-point strategic plan focused on revitalizing growth and improving profitability. The key priorities include improving Irwin's historically inefficient supply chain, ramping up new product development for the Irwin brand, and driving off-Amazon demand generation to counter the algorithm-related weakness seen with brands like Dr. Tobias.

Furthermore, the company plans to leverage Irwin's strong wholesale sales team to cross-sell other FitLife products, like MusclePharm, into the food, drug, and mass-market retail channels where Irwin has an established presence. Early progress has already been seen, with six MusclePharm products securing placement in a regional grocery chain. The final initiative is a focus on reducing selling, general, and administrative (SG&A) expenses through operational efficiencies.

While Judd expressed encouragement over Irwin's online growth, he remained cautious about the near-term outlook. "At this point we are not able to determine whether it will fully or only partially offset the weakness we are experiencing elsewhere in our business," he concluded, reflecting the pivotal and uncertain period FitLife now navigates.